BETA: Please send your feedback!

Collegium Pharmaceutical

NAS:COLL

Pharmaceuticals: Other

$494.91mm
SMALL cap
$14.48 (-2.36%)
-16.6854%
since start of 2019
  • 1
  • Carbon Footprint
  • Pollution Prevention
  • Water Conservation
  • Data Privacy
  • Consumer Health
  • Employee Satisfaction
  • Workplace Safety
  • Corp Gov
  • Ethical Practices
  • Conflict Materials
  • Forced Labor
  • Gender Diversity
  • 1
  • CF
  • PP
  • WC
  • DP
  • CH
  • ES
  • WS
  • CG
  • EP
  • CM
  • FL
  • GD
  • 1
  • 2
  • 3
  • 4
  • 5

About

Collegium Pharmaceutical, Inc. is a specialty pharmaceutical company, which engages in the development and commercialization of next-generation abuse-deterrent products that incorporate its patented DETERx platform technology for the treatment of chronic pain and other diseases. Its products includes Xtampza ER, and ONSOLIS. Xtampza ER provides adequate pain control while maintaining its extended-release drug release profile after being subjected to common methods of abuse and accidental misuse. The ONSOLIS is a transmucosal immediate release fetanyl film indicated for the management of breakthrough pain in cancer patients. The company was founded by Michael Thomas Heffernan in October 2003 and is headquartered in Canton, MA.
website

Headquarters

780 Dedham Street
Suite 800
Canton, MA 02021

Executives

Name Title Gender
Jane C. I. Hirsh Founder Female
Michael Thomas Heffernan Chairman, President & Chief Executive Officer Male
Paul Brannelly, CPA Chief Financial Officer & Executive Vice President Male
Timothy Hermes VP-Government Affairs & Alliance Development Male
John Weet, PhD VP-Regulatory Affairs & Quality Assurance Male

Mindful Investing Summary

  • 1
  • 2
  • 3
  • 4
  • 5
  • Carbon Footprint N/A
  • Pollution Prevention N/A
  • Water Conservation N/A
  • Data & Privacy Protection N/A
  • Consumer Health, Wellness & Safety N/A
  • Employee Ownership, Satisfaction, Benefits & Pay N/A
  • Workplace Health and Safety N/A
  • Integrity of Corporate Governance N/A
  • Ethical Practices N/A
  • Usage of Conflict Materials N/A
  • Forced Labor N/A
  • Diversity of Corporate Leadership 1

Collegium Pharmaceutical - Competitors and Related Companies

How Collegium Pharmaceutical stacks up to its peers in the Pharmaceuticals: Other industry or with competing business segments.

Collegium Pharmaceutical

NAS:COLL

Pharmaceuticals: Other

$494.91mm
SMALL cap
$14.48 (-2.36%)
-16.6854%
since start of 2019
  • 1
  • Carbon Footprint
  • Pollution Prevention
  • Water Conservation
  • Data Privacy
  • Consumer Health
  • Employee Satisfaction
  • Workplace Safety
  • Corp Gov
  • Ethical Practices
  • Conflict Materials
  • Forced Labor
  • Gender Diversity
  • 1
  • CF
  • PP
  • WC
  • DP
  • CH
  • ES
  • WS
  • CG
  • EP
  • CM
  • FL
  • GD
  • 1
  • 2
  • 3
  • 4
  • 5
Loading…